Skip to main content
Log in

Epstein-Barr-Virus-assoziierte Lymphoproliferationen und Lymphome

Epstein-Barr virus-associated lymphoproliferations and lymphomas

  • Schwerpunkt
  • Published:
Der Pathologe Aims and scope Submit manuscript

Zusammenfassung

Das Epstein-Barr-Virus (EBV) ist ein lymphotropes Herpesvirus, das weltweit mehr als 95 % aller Menschen infiziert. Durch die Infektion von B-Zellen kann es, meist im Rahmen von Immundefizienzzuständen unterschiedlicher Ursache, zu einem breiten Spektrum von Lymphoproliferationen und Lymphomen führen. Dieses umfasst mononukleoseähnliche Veränderungen und Hyperplasien unterschiedlicher Lymphozytenpopulationen bis hin zu aggressiven Non-Hodgkin-Lymphomen und dem klassischen Hodgkin-Lymphom. Diese Läsionen treten häufig extranodal auf. Das histologische Bild ist oft polymorph mit angioinvasivem Wachstum und Nekrosen. Hilfreich für die genaue Klassifikation sind neben den klinischen Angaben der immunhistologische Nachweis einer CD30-Expression in den infizierten aktivierten Zellen und die Darstellung von EBV-kodierten Proteinen und RNA-Transkripten.

Abstract

Epstein-Barr virus (EBV) is a lymphotropic herpesvirus infecting > 95 % of the worldwide population. In case of an immunodeficiency of various causes, the virus may lead to the development of a wide spectrum of lymphoproliferations and lymphomas. This encompasses mononucleosis-like lymphoproliferations, hyperplasias of various B-cell subsets as well as aggressive non-Hodgkin lymphomas and classical Hodgkin lymphoma. These lesions occur frequently extranodal and present with a polymorphous histology with angioinvasion and necrosis. Clinical data combined with the immunohistological detection of CD30 expression in the activated infected cells and the demonstration of EBV-encoded proteins and RNA transcripts are helpful for achieving precise classification of these lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6
Abb. 7
Abb. 8

Literatur

  1. Epstein MA, Achong BG, Barr YM (1964) Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1(7335):702–703

    Article  PubMed  CAS  Google Scholar 

  2. Kutok JL, Wang F (2006) Spectrum of Epstein-Barr virus-associated diseases. Annu Rev Pathol 1:375–404

    Article  PubMed  CAS  Google Scholar 

  3. Rickinson AB, Kieff E (2007) Epstein-Barr virus. In: Knipe DM, Howley PM, Griffin DE, Martin MA, Lamb RA, Roizman B, Straus SE (Hrsg) Fields virology. Lippincott-Williams & Wilkins, Philadelphia, S 2655–2700

  4. Dirmeier U et al (2005) Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene 24(10):1711–1717

    Article  PubMed  CAS  Google Scholar 

  5. Wiesner M et al (2008) Conditional immortalization of human B cells by CD40 ligation. PloS One 3(1):e1464

    Article  PubMed  Google Scholar 

  6. Mancao C, Hammerschmidt W (2007) Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival. Blood 110(10):3715–3721

    Article  PubMed  CAS  Google Scholar 

  7. Feederle R et al (2000) The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J 19(12):3080–3089

    Article  PubMed  CAS  Google Scholar 

  8. Sinclair AJ (2003) bZIP proteins of human gammaherpesviruses. J Gen Virol 84(Pt 8):1941–1949

    Article  PubMed  CAS  Google Scholar 

  9. Hochberg D et al (2004) Demonstration of the Burkitt’s lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc Nat Acad Sci U S A 101(1):239–244

    Article  CAS  Google Scholar 

  10. Thorley-Lawson DA, Gross A (2004) Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350(13):1328–1337

    Article  PubMed  CAS  Google Scholar 

  11. Louissaint A Jr et al (2012) Infectious mononucleosis mimicking lymphoma: distinguishing morphological and immunophenotypic features. Mod Pathol 25(8):1149–1159

    Article  PubMed  CAS  Google Scholar 

  12. Anagnostopoulos I et al (1995) Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 85(3):744–750

    PubMed  CAS  Google Scholar 

  13. Trappe R et al (2012) Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. Lancet Oncol 13(2):196–206

    Article  PubMed  CAS  Google Scholar 

  14. Hummel M et al (2006) A biologic definition of Burkitt’s lymphoma from transcriptional and genomic profiling. N Engl J Med 354(23):2419–2430

    Article  PubMed  CAS  Google Scholar 

  15. Oyama T et al (2003) Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol 27(1):16–26

    Article  PubMed  Google Scholar 

  16. Nakamura S, Jaffe ES, Swerdlow SH (2008) EBV positive diffuse large B-cell lymphoma of the elderly. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon, S 243–244

  17. Hoeller S et al (2010) Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations. Hum Pathol 41(3):352–357

    Article  PubMed  Google Scholar 

  18. Hofscheier A et al (2011) Geographic variation in the prevalence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a comparative analysis of a Mexican and a German population. Mod Pathol 24(8):1046–1054

    Article  PubMed  Google Scholar 

  19. Dojcinov SD et al (2011) Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood 117(18):4726–4735

    Article  PubMed  CAS  Google Scholar 

  20. Dojcinov SD et al (2010) EBV positive mucocutaneous ulcer – a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol 34(3):405–417

    Article  PubMed  Google Scholar 

  21. Asano N et al (2009) Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients. Blood 113(12):2629–2636

    Article  PubMed  CAS  Google Scholar 

  22. Guinee D Jr et al (1994) Pulmonary lymphomatoid granulomatosis. Evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis. Am J Surg Pathol 18(8):753–764

    Article  PubMed  Google Scholar 

  23. Narimatsu H et al (2007) Clinicopathological features of pyothorax-associated lymphoma; a retrospective survey involving 98 patients. Ann Oncol 18(1):122–128

    Article  PubMed  CAS  Google Scholar 

  24. Nakatsuka S et al (2002) Pyothorax-associated lymphoma: a review of 106 cases. J Clin Oncol 20(20):4255–4260

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt für sich und seine Koautorin an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. Anagnostopoulos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anagnostopoulos, I., Jöhrens, K. Epstein-Barr-Virus-assoziierte Lymphoproliferationen und Lymphome. Pathologe 34, 262–271 (2013). https://doi.org/10.1007/s00292-013-1750-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00292-013-1750-9

Schlüsselwörter

Keywords

Navigation